The placebo effect in asthma

Current Allergy and Asthma Reports

Volumn 14, Issue 8, 2014, Pages

  Dutile, Stefanie ^a   Kaptchuk, Ted J ^a   Wechsler, Michael E ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

Asthma; Clinical outcomes; Clinical trial design; Expectancy; Placebo effect

Indexed keywords

PLACEBO;

ASTHMA; CLINICAL TRIAL (TOPIC); HUMAN; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PLACEBO EFFECT; REVIEW; STUDY DESIGN; BIOLOGICAL MODEL; IMMUNOLOGY; TREATMENT OUTCOME;

ASTHMA; CLINICAL TRIALS AS TOPIC; HUMANS; MODELS, IMMUNOLOGICAL; PLACEBO EFFECT; TREATMENT OUTCOME;

EID: 84902707467     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-014-0456-2     Document Type: Review

References (56)

1. de Craen AJ, Kaptchuk TJ, Tijssen JG, Kleijnen J. Placebos and placebo effects in medicine: historical overview. J R Soc Med. 1999;92(10):511-5. (Pubitemid 29495451)
2. Shapiro AK, Shapiro E. The powerful placebo: from ancient priest to modern physician. Baltimore: The Johns Hopkins University Press; 1997.
3. Cabot RC. The use of truth and falsehood in medicine: an experimental study. Am Med. 1903;5:344-9.
4. Brody H, Miller FG. Lessons from recent research about the placebo effect - from art to science. JAMA. 2011;306(23):2612-3. doi:10.1001/jama.2011.1850.
5. Brody H. The placebo response. Recent research and implications for family medicine. J Fam Pract. 2000;49(7):649-54. (Pubitemid 30663065)
6. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA. 1994;271(20):1609-14. (Pubitemid 24155623)
7. Benedetti F. Placebo effects: understanding the mechanisms in health and disease. Oxford: Oxford University Press; 2009. This book critically reviews the mechanisms of placebo and placebo-related effects across all medical conditions, diseases, and therapeutic interventions.
8. Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Ann Intern Med. 2000;133(6):464-70.
9. Temple RJ.When are clinical trials of a given agent vs. placebo no longer appropriate or feasible? Control Clin Trials. 1997;18(6):613-20. (Pubitemid 27520849)
10. Kaptchuk TJ. Powerful placebo: the dark side of the randomised controlled trial. Lancet. 1998;351(9117):1722-5. doi:10.1016/s0140-6736(97)10111-8. (Pubitemid 28254542)
11. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. NEngl JMed. 2001;344(21):1594-602. doi:10.1056/nejm200105243442106. (Pubitemid 32479913)
12. Ernst E, Resch K. Concept of true and perceived placebo effects. BMJ. 1995;311(7004):551-3.
13. Kaptchuk TJ, Kelley JM, Deykin A, Wayne PM, Lasagna LC, Epstein IO, et al. Do "placebo responders" exist? Contemp Clin Trials. 2008;29(4):587-95. doi:10.1016/j.cct.2008.02.002.
14. Program CNAC. Asthma's impact on the nation. Atlanta, GA. http://www.cdc.gov/asthma/impacts-nation/default.htm. 2014.
15. Mackenzie JN. The production of the so-called "rose cold" by means of an artificial rose: with remarks and historical notes. Am J Med Sci. 1886;181:45.
16. Colloca L, Miller FG. Role of expectations in health. Curr Opin Psychiatry. 2011;24(2):149-55. doi:10.1097/YCO.0b013e328343803b.
17. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron. 2008;59(2):195-206. doi:10.1016/j.neuron.2008.06.030. (Pubitemid 352033692)
18. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565-90. doi:10.1146/annurev.psych.59.113006.095941.
19. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010;375(9715):686-95. doi:10.1016/s0140-6736(09)61706-2. This article discusses the ethical use of placebo mechanisms that are inherent in routine clinical care and the use of treatments that stimulate placebo effects.
20. Meissner K, Bingel U, Colloca L, Wager TD, Watson A, Flaten MA. The placebo effect: advances from different methodological approaches. J Neurosci. 2011;31(45):16117-24. doi:10.1523/jneurosci.4099-11.2011. This article provides an overview of the processes involved in the formation of placebo responses by combining research findings from behavioral, psychophysiological, and neuroimaging methods.
21. Kaptchuk TJ. Placebo studies and ritual theory: a comparative analysis of Navajo, acupuncture and biomedical healing. Philos Trans R Soc Lond B Biol Sci. 2011;366(1572):1849-58. doi:10.1098/rstb.2010.0385.
22. Luparello T, Lyons H, Bleecker E, McFadden E. Influences of suggestion on airway reactivity in asthmatic subjects. Psychosom Med. 1968;30(6):819-25.
23. McFadden E, Luparello T, Lyons H, Bleecker E. The mechanismof action of suggestion in the induction of acute asthma attacks. Psychosom Med. 1969;31(2):134-43.
24. Castro MRA, Laviolette M, Fiterman J, De Andrade Lima M, Shah PL, Fiss E, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med. 2010;181(2):116-24.
25. Benedetti F. The placebo response: science versus ethics and the vulnerability of the patient. World Psychiatry. 2012;11(2):70-2.
26. Vits S, Cesko E, Benson S, Rueckert A, Hillen U, Schadendorf D, et al. Cognitive factors mediate placebo responses in patients with house dust mite allergy. PLoS One. 2013;8(11):e79576. doi:10.1371/journal.pone.0079576.
27. Goebel M, Meykadeh N, Kou W, Schedlowski M, Hengge U. Behavioral conditioning of antihistamine effects in patients with allergic rhinitis. Psychother Psychosom. 2008;77(4):227-34. (Pubitemid 351685447)
28. Vits S, Cesko E, Enck P, Hillen U, Schadendorf D, Schedlowski M. Behavioural conditioning as the mediator of placebo responses in the immune system. Philos Trans R Soc Lond B Biol Sci. 2011;366(1572):1799-807.
29. Benedetti F, Amanzio M, Baldi S, Casadio C, Maggi G. Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur J Neurosci. 1999;11:625-31. (Pubitemid 29050464)
30. de la Fuente-Fernández R, Ruth T, Sossi V, Schulzer M, Calne D, Stoessl A. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science. 2001;293(5532):1164-6. (Pubitemid 32758101)
31. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci. 2004;7(6):587-8. (Pubitemid 38691896)
32. Meissner K, Kohls N, Colloca L. Introduction to placebo effects in medicine: mechanisms and clinical implications. Philos Trans R Soc Lond B Biol Sci. 2011;366(1572):1783-9.
33. Albring A, Wendt L, Benson S, Witzke O, Kribben A, Engler H, et al. Placebo effects on the immune response in humans: the role of learning and expectation. PLoS One. 2012;7(11):e49477.
34. Lasagna L, Mosteller F, Von Felsinger JM, Beecher HK. A study of the placebo response. Am J Med. 1954;16(6):770-9.
35. Joyce CR. Consistent differences in individual reactions to drugs and dummies. Br J Pharmacol Chemother. 1959;14:512-21.
36. Leigh R, MacQueen G, Tougas G, Hargreave FE, Bienenstock J. Change in forced expiratory volume in 1 second after sham bronchoconstrictor in suggestible but not suggestion-resistant asthmatic subjects: a pilot study. Psychosom Med. 2003;65(5):791-5. (Pubitemid 37163385)
37. Kemeny ME, Rosenwasser LJ, Panettieri RA, Rose RM, Berg-Smith SM, Kline JN. Placebo response in asthma: a robust and objective phenomenon. J Allergy Clin Immunol. 2007;119(6):1375-81. doi:10.1016/j.jaci.2007.03.016. (Pubitemid 46855863)
38. Agid O, Siu CO, Potkin SG, Kapur S, Watsky E, Vanderburg D, et al. Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010. Am J Psychiatry. 2013;170(11):1335-44. doi:10.1176/appi.ajp.2013.12030315.
39. Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, et al. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One. 2012;7(10):e48135. doi:10.1371/journal.pone. 0048135.
40. Tracey I. Getting the pain you expect:mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med. 2010;16(11):1277-83. doi:10.1038/nm.2229. This article discusses how placebo and nocebo effects are produced and what biological and psychological factors influence variances in the magnitude of the effect.
41. Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med. 2011;17(10):1228-30. doi:10.1038/nm.2435.
42. Wise RA, Bartlett SJ, Brown ED, Castro M, Cohen R, Holbrook JT, et al. Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol. 2009;124(3):436-44. doi:10.1016/j.jaci.2009.05.041. 44e1-8.
43. May O, Hansen NC. Comparison of terbutaline, isotonic saline, ambient air and non-treatment in patients with reversible chronic airway obstruction. Eur Respir J. 1988;1(6):527-30.
44. Isenberg SA, Lehrer PM, Hochron S. The effects of suggestion on airways of asthmatic subjects breathing room air as a suggested bronchoconstrictor and bronchodilator. J Psychosom Res. 1992;36(8):769-76.
45. Wechsler ME, Kelley JM, Boyd IO, Dutile S, Marigowda G, Kirsch I, et al. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med. 2011;365(2):119-26. doi:10.1056/NEJMoa1103319.
46. Kirsch I. Philosophical transactions of the Royal Society of London. Series B, biological sciences. Preface. Philos Trans R Soc Lond B Biol Sci. 2011;366(1572):1781-2.
47. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010;5(12):e15591. doi:10.1371/journal.pone.0015591. http://www.nejm.org/doi/full/10.1056/NEJMoa1103319.
48. Kam-Hansen S, Jakubowski M, Kelley J, Kirsch I, Hoaglin D, Kaptchuk T, et al. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med. 2014;6(218):218ra5.
49. Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010;(1):Cd003974. doi:10.1002/14651858. CD003974.pub3.
50. Moerman DE. Meaningful placebos-controlling the uncontrollable. N Engl J Med. 2011;365(2):171-2. doi:10.1056/NEJMe1104010.
51. NAEPP. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007. J Allergy Clin Immunol. 2007;120(5 Suppl):S94-138. doi:10.1016/j.jaci.2007.09.043.
52. Radeos MS, Leak LV, Lugo BP, Hanrahan JP, Clark S, Camargo Jr CA. Risk factors for lack of asthma self-management knowledge among ED patients not on inhaled steroids. Am J Emerg Med. 2001;19(4):253-9. (Pubitemid 32642148)
53. Kendrick AH, Higgs CM, Whitfield MJ, Laszlo G. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ. 1993;307(6901):422-4. (Pubitemid 23227471)
54. Lund K, Vase L, Petersen GL, Jensen TS, Finnerup NB. Randomised controlled trials may underestimate drug effects: balanced placebo trial design. PLoS One. 2014;9(1):e84104. doi:10.1371/journal.pone.0084104.
55. Olfson M, Marcus SC. Decline in placebo-controlled trial results suggests new directions for comparative effectiveness research. Health Aff (Millwood). 2013;32(6):1116-25. doi:10.1377/hlthaff.2012.1353.
56. Heger M. Trial designs advance to overcome bitter pill of placebo effect. Nat Med. 2013;19(11):1353. doi:10.1038/nm1113-1353.